Chimerix (CMRX) Form 3 CHIMERIX / Michael Albert Alrutz ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Alrutz Michael Albert

(Last) (First) (Middle)

C/O CHIMERIX, INC.

2505 MERIDIAN PARKWAY, SUITE 340

(Street)

DURHAM NC 27713

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/05/2019

3. Issuer Name and Ticker or Trading Symbol
CHIMERIX INC [ CMRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Principal Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	56,645(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	06/01/2022	Common Stock	1,485	2.38	D
Stock Option (Right to Buy)	(2)	01/28/2024	Common Stock	9,000	18.75	D
Stock Option (Right to Buy)	(2)	08/26/2024	Common Stock	20,000	25.75	D
Stock Option (Right to Buy)	(2)	01/28/2025	Common Stock	28,000	39.41	D
Stock Option (Right to Buy)	08/01/2015(3)	08/01/2025	Common Stock	15,000	53.74	D
Stock Option (Right to Buy)	01/08/2016(3)	01/08/2026	Common Stock	178,000	8.06	D
Stock Option (Right to Buy)	01/24/2017(3)	01/24/2027	Common Stock	45,750	5.14	D
Stock Option (Right to Buy)	01/25/2018(3)	01/25/2028	Common Stock	135,000	4.68	D
Stock Option (Right to Buy)	01/23/2019(3)	01/23/2029	Common Stock	176,000	2.41	D

Explanation of Responses:

1. Amount includes (i) 12,500 unvested shares pursuant to a restricted stock unit award issued on May 9, 2016 and (ii) 11,437 unvested shares pursuant to a restricted stock unit award issued on January 24, 2017.

2. Fully vested and exercisable.

3. 1/48th of the shares will vest each month over a four year period following the vesting commencement date.

Remarks:

	/s/ Michael Alrutz	02/07/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.